XML 15 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (930,702) $ (238,877)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation 83,728  
Amortization of debt discount to interest expense   82,500
Amortization of prepaid stock-based expense 101,222
Net unrealized gain on equity investments (38,750)  
Change in operating assets and liabilities:    
(Increase) decrease in inventory (11,181) 453
Increase in prepaid expenses and other current assets - current (90,539) (13,034)
Increase in prepaid expenses - non-current (19,375)  
Increase in accounts payable and accrued expenses 110,967 51,297
Increase in accrued interest payable - related party   52
Increase in deferred revenue 482,812  
NET CASH USED IN OPERATING ACTIVITIES (311,818) (117,609)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Collection on note receivable 23,500
NET CASH PROVIDED BY INVESTING ACTIVITIES 23,500  
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net proceeds from sale of preferred stock 3,794,102 15,000
Advance from a related party 2,366  
NET CASH PROVIDED BY FINANCING ACTIVITIES 3,796,468 15,000
NET DECREASE IN CASH AND CASH EQUIVALENTS: 3,508,150 (102,609)
CASH AND CASH EQUIVALENTS - beginning of period 1,128,389 111,752
CASH AND CASH EQUIVALENTS - end of period 4,636,539 9,143
Cash paid during the period for:    
Interest
Income taxes
Non-Cash investing and financing activities:    
Increase in equity investments recorded as deferred revenue pursuant to a patent license agreement $ 531,250